Advanced Prostate Cancer Consensus Conference

Advanced Prostate Cancer
Consensus Conference: APCCC 2019

29-31 August 2019, Basel/Switzerland

APC Society

The APC Society is a non-profit organisation that aims to improve the treatment and care of men with advanced prostate cancer. The society organises the Advanced Prostate Cancer Consensus Conference (APCCC) and is the legal representative of APCCC in Switzerland.

Executive Committee

Prof. Dr. Silke Gillessen

President

Chief Physician, Department of Oncology/Haematology, Kantonsspital St. Gallen, Switzerland

Prof. Silke Gillessen, a Medical Oncologist at Kantonsspital St. Gallen in Switzerland, specialises in genitourinary cancer and leads its clinical trials unit for oncology and haematology. Prof. Gillessen completed her specialist training in Medical Oncology at the University Hospital of Basel and the Cantonal Hospital St.Gallen in Switzerland. From 1997 to 2000, she was a clinical research fellow at the Dana Farber Cancer Institute, Harvard Medical School in Boston, USA. After returning to Switzerland, Prof. Gillessen built up the unit for genitourinary cancer in St. Gallen and served for two terms as president of the SAKK GU group. She now chairs the EORTC Genito Urinary Cancers Group. Together with Dr. Omlin, Dr. Gillessen initiated the Advanced Prostate Cancer Consensus Conference, which was held first in March 2015 and again in 2017.

 


Prof. em. Dr. med. Thomas Cerny

Vice President

Consultant Physician, Department of Oncology/Haematology, Kantonsspital St. Gallen, Switzerland

Thomas Cerny is Prof. med. for Medical Oncology at the University of Bern, Switzerland. From 1998 to 2017, he served as Chief of the Department of Oncology-Haematology at the Kantonsspital St. Gallen. Prof. Cerny received his medical training in Switzerland (Inselspital, University Hospital of Bern) and the United Kingdom (Christie Hospital and Patterson Institute, Manchester). His research focuses on clinical pharma-oncology, especially developing and exploring new drugs and improving therapies for patients with rare cancers such as sarcomas. Prof. Cerny has decades of experience conducting and participating in national and international clinical studies for patients with lung cancer, malignant lymphoma, and many other types of malignancies. He has more than 250 peer-reviewed publications.

Additionally, Prof. Cerny is a national leader in the political aspects of improving patient care, quality of life, and equal access to diagnostic and therapeutic progress in oncology. He is a former president of Oncosuisse, which houses the federal National Strategy against Cancer (NSK), and of the Swiss Cancer League (KLS), which leads this project. Prof. Cerny also is acting president of the best-known foundation in Cancer Research in Switzerland (KFS) and serves on the board of the Human Medicine Expert Committee (HMEC) of Swissmedic./span>

 


PD Dr. Aurelius Omlin

General Secretary / Treasurer

Senior Physician, Department of Oncology/Haematology, Kantonsspital St. Gallen, Switzerland

Dr. Aurelius Omlin is a Medical Oncologist at Kantonsspital St. Gallen in Switzerland who focuses on genitourinary cancer and early-phase clinical trials. Dr. Omlin performed his specialist training in Medical Oncology at the University Hospital of Berne, the regional hospital in Thun and the Cantonal Hospital St. Gallen in Switzerland. From 2010 – 2013 he was a clinical research fellow at the Royal Marsden NHS Foundation Trust and the Institute of Cancer Research (ICR) in London under Prof Johann de Bono focusing on early clinical trials especially for men with advanced prostate cancer. After his return to Switzerland, Dr. Omlin together with Prof Silke Gillessen initiated the Advanced Prostate Cancer Consensus Conference, which was first held in March 2015 and then again in 2017.

 


Dr. Ruth Lyner

Advisory Member

Dr. Ruth Lyner is a lawyer who for 25 years has worked as a designer and distributor for sports fashion. She founded her own company together with her husband who was diagnosed with prostate cancer. In APC, Dr. Lyner represents patients and their family members.

 


Claude Thomann

Advisory Member

Dr. iur., LL.M., Rechtsanwalt, Konsulent, Bern

Dr. Claude Thomann is a founder and senior partner of one of Switzerland’s largest law firms. Since 1980, he has been the legal advisor of the Swiss Cancer League and other associations and foundations with similar objectives.